Importantly, Ffar2 modulation did not affect lymphocytes of adaptive immunity, nor ILC1 or ILC2, but potentiated ILC3 proliferation and IL-22 production as the basis for the mechanism of action for the observed protective effect of Cpd1 against colitis and Citrobacter rodentium infection [16]. The gene discussed is IL22; the disease is colitis.